Medical Developments International Limited (ASX:MVP)

ASX:MVP Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Revenue Revenue Growth	42.57	42.57	39.06	33.15	32.34	21.94
Revenue Growth	4.74%	8.99%	17.82%	2.51%	47.37%	-13.17%
Gross Profit Gross Profit Growth	30.67	30.67	29.43	24.37	22.21	15.21
Operating Income Operating Income Growth	2.39	2.39	0.14	-14.12	-17.3	-12.55
Net Income Net Income Growth	0.63	0.63	0.09	-40.99	-5.61	-12.41
Earnings Per Share EPS Growth	0.01	0.01	0.00	-0.47	-0.07	-0.17
EPS Growth	-	562.50%	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Pain Management Pain Management Growth	26.19	21.3	20.45	13.27
Respiratory Respiratory Growth	12.87	11.85	11.72	8.22
Total Total Growth	39.06	33.15	32.34	21.94

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Investments Cash & Investments Growth	14.37	14.37	17.84	9.74	24.66	20.4
Total Debt Total Debt Growth	1.67	1.67	1.99	2.29	2.56	2.81
Net Cash (Debt) Net Cash Growth	12.7	12.7	15.85	7.45	22.1	17.59
Net Cash Growth	-15.57%	-19.85%	112.74%	-66.30%	25.68%	-47.08%
Net Cash Per Share Net Cash Per Share Growth	0.11	0.11	0.14	0.09	0.26	0.25

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating Cash Flow Operating Cash Flow Growth	5.75	5.75	-0.04	-10.78	-16.5	-10.78
Capital Expenditures CapEx Growth	-0.48	-0.48	-0.44	-0.79	-1.78	-1.2
Free Cash Flow Free Cash Flow Growth	5.27	5.27	-0.49	-11.57	-18.28	-11.98
Free Cash Flow Growth	984.16%	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Gross Margin	72.05%	72.05%	75.35%	73.50%	68.69%	69.31%
Operating Margin	5.61%	5.61%	0.36%	-42.60%	-53.51%	-57.17%
Pretax Margin	1.18%	1.18%	0.43%	-99.33%	-23.17%	-72.50%
Profit Margin	1.47%	1.47%	0.24%	-123.66%	-17.34%	-56.54%
FCF Margin	12.38%	12.38%	-1.24%	-34.91%	-56.53%	-54.58%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	89.62	71.09	659.17	-	-	-
Forward PE	-	65.83	22.54	208.39	208.39	208.39
P/FCF Ratio	10.16	8.45	-	-	-	-
PS Ratio	1.26	1.05	1.59	1.05	2.07	4.74

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error